Episode 065: Breast Cancer Series, Pt. 10-ER+, Metastatic Breast Cancer
The Fellow on Call: The Heme/Onc Podcast
00:00
Re-biopsy, Prognosis, and Endocrine Backbone
Emphasis on biopsying progression (ESR1/PIK3CA), prognosis for bone-only disease, and endocrine-first strategy: when to use AIs vs CERDs, plus bone-targeted agents (zoledronic acid/denosumab).
Play episode from 06:46
Transcript
